• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Budd-Chiari syndrome in children: Challenges and outcome

    2023-12-05 07:17:00ArghyaSamantaMoinakSenSarmaRajanikantYadav
    World Journal of Hepatology 2023年11期

    Arghya Samanta,Moinak Sen Sarma,Rajanikant Yadav

    Abstract Budd-Chiari syndrome (BCS) is an uncommon disease of the liver,characterised by obstruction of the hepatic venous outflow tract.The etiological spectrum of BCS as well as venous obstruction pattern show wide geographical and demographic variations across the globe.Compared to adults with BCS,children have primary BCS as the predominant etiology,earlier clinical presentation,and hence better treatment outcome.Underlying prothrombotic conditions play a key role in the etiopathogenesis of BCS,though work-up for the same is often unyielding in children.Use of next-generation sequencing in addition to conventional tests for thrombophilia leads to better diagnostic yield.In recent years,advances in radiological endovascular intervention techniques have revolutionized the treatment and outcome of BCS.Various non-invasive markers of fibrosis like liver and splenic stiffness measurement are being increasingly used to assess treatment response.Elastography techniques provide a novel non-invasive tool for measuring liver and splenic stiffness.This article reviews the diagnostic and therapeutic advances and challenges in children with BCS.

    Key Words: Budd-Chiari syndrome;Radiological endovascular intervention;Transjugular intrahepatic porto-systemic shunt;Direct intrahepatic porto-systemic shunt;Liver stiffness;Splenic stiffness;Shear-wave elastography

    INTRODUCTION

    Budd-Chiari syndrome (BCS) is a rare vascular disease of the liver with a promising outcome if treated optimally on time.It occurs due to obstruction in the hepatic venous outflow anywhere from the hepatic vein (HV) to the entry of the inferior vena cava (IVC) to the heart[1].Involvement of at least two HV leads to an increase in hepatic sinusoidal pressure and congestion resulting in symptoms of BCS[2].Global epidemiological data on BCS is scarce[3].The incidence of BCS reported in the published literature ranges from 0.2 to 4.1 cases per million population per year,with an estimated prevalence of 2.4-7.7 per million population in Asian countries[4,5] and of 1.4-4.0 per million population in Western countries[6-9].Population-based study on the epidemiology of BCS in children is lacking.Large case series on pediatric BCS are available[10-15].Chronic BCS constitutes 3%-7% of cases of portal hypertension (PHTN) in the pediatric population[10,11].So far,interventional and long-term outcome studies in children are limited[12-15].Over the years there has been remarkable progress in understanding the evolution of this disease.This review aims to discuss the various aspects of BCS,including recent updates on diagnostic and treatment modalities for BCS in children as well as the challenges in them.The review will particularly focus on chronic BCS which accounts for the majority of cases in children.

    VARIATIONS IN THE ETIOLOGICAL SPECTRUM OF BCS

    Primary BCS is an obstruction of the hepatic venous outflow tract that occurs due to an endoluminal venous lesion(thrombosis or web) resulting from an unidentifiable cause or an inherent prothrombotic condition.Secondary BCS results from obstruction from an invasive lesion (malignant tumor or a parasitic mass) or extrinsic compression by spaceoccupying lesions (abscesses,cysts,and benign or malignant solid tumors)[1].The above inflammatory or neoplastic conditions can also result in a secondary prothrombotic state which further adds to thrombosis in the HV.Secondary causes of BCS are common in adults as compared to children[16].Global variations in the type of BCS may reflect different predisposing factors in different countries.Studies from Western countries have shown HV to be the most common site of obstruction in BCS[17,18].There seems to be a shift in the pattern of obstruction in studies from Asian countries.Earlier,isolated IVC obstruction was the most type of BCS in Asian patients.Recent studies from China[19,20]as well as India[16,21,22] have noted that a combined IVC and HV obstruction (40%-75%) is the most common type of BCS.A similar pattern has also been documented in Indian children with BCS[12-15].Over the years,the changes in the spectrum have been better documented due to the advancements in radiology such as high-resolution Doppler ultrasonography (DUS) and non-invasive venography by computed tomography (CT),and magnetic resonance imaging.

    BCS AND THROMBOPHILIA

    Primary BCS is often regarded as a result of a unique constellation of prothrombotic conditions.The inherited prothrombotic conditions associated with BCS are protein C deficiency,protein S deficiency,antithrombin III deficiency,factor V Leiden mutation,prothrombin gene mutation,and hyper-homocysteinemia with methyltetrahydrofolate reductase mutation[23].Acquired prothrombotic conditions like antiphospholipid syndrome (APLS),paroxysmal nocturnal hemoglobinuria (PNH),sickle cell disease,and myeloproliferative disorders (MPD) also predispose to BCS[24,25].Systemic disorders like inflammatory bowel disease,Behcet’s disease,and other inflammatory intraabdominal lesions can cause BCS in adults but rarely in children[26].Recent studies reported an identifiable etiology in 80-84% of cases in adults[27-30].Underlying myeloproliferative disorders (45%-51%) and exposure to oral contraceptives (50%) are the commonest etiologies[27,28].In over 25% of cases,more than one thrombophilic state may be present[29,30].From the available pediatric literature,we understand that the prothrombotic workup in children is often unyielding,inconclusive,or ambiguous.Table 1 summarizes the findings of prothrombotic workup of prior pediatric studies on BCS[11-14,31-35].As shown,most of the pediatric publications are from India including authors’ own experience.One of the majordrawbacks is the lack of in-depth testing for prothrombotic conditions.Shuklaet al[32] found thrombophilia in 42% of children and 37% of adolescents.The commonest etiologies were Factor V Leiden in children and JAK 2V617F mutation in adolescents.Although thrombophilia may be present in 68%-75% of children,the cause-and-effect relationship is not established[12,32].Relative and multiple deficiencies of proteins C and S,antithrombin III deficiency,and hyperhomocysteinemia (9%-15%) may be a result of an advanced liver disease resulting in poor synthetic function of the liver rather than a true thrombophilia state[29].In a systematic review of adults with BCS,MPD was found to be more associated with HV block (16%-62%) than IVC block (4%-5%)[36].

    Table 1 Summary of various pediatric studies (national) of thrombophilia profile in children with Budd-Chiari syndrome

    Oral anticoagulants may alter proteins C and S,activated protein C levels,and lupus anticoagulant levels.Hence these tests are best performed before starting thromboprophylaxis.Further,the presence of hypersplenism and hemodilution in cirrhosis with portal hypertension masks the peripheral blood findings of a concomitant MPD[29].Genetic testing is the gold standard for documentation of thrombophilia.In a study of 80 adults with non-cirrhotic splanchnic vein thrombosis,next-generation sequencing was able to identify JAK2 mutations,previously undetected by conventional techniques in one-third of cases[37].

    It is also suggested that the prevalence of various thrombophilic disorders is different between younger children and adolescents.In a study from India,the JAK2V617F was found to be common in adolescents but not in children[32].Recently it has been shown that adolescent venous thromboembolism is multifactorial in the majority with more than two risk factors at diagnosis[38].Warfarin is the most commonly used oral anticoagulant in BCS patients,especially after radiological intervention.As it has a narrow therapeutic window,the dose needs to be titrated with regular monitoring of international normalized ratio (INR) (target: 2-3).Vitamin K epoxide reductase complex subunit C1 (VKORC1) and cytochrome P450 2C9 (CYP2C9) are the two major genes involved in the metabolism of warfarin and they determine the dose requirement of warfarin[39].CYP2C9 metabolizes the more potent S-enantiomer of warfarin while VKORC1 is the target protein for warfarin.Multiple single nucleotide polymorphisms have been described in these genes,of which the most important ones are CYP2C9*2,CYP2C9*3,and VKORC1 heterozygous haplotype GA and homozygous AA[40].Thus,the patient’s genotype is a major determinant of not only the dose requirement but also the risk of anticoagulationrelated complications.In a study from India in adults with BCS,patients with the presence of mutations in VKORC1 or CYP2C9 were associated with an increased risk of bleeding[41].More intensive monitoring while on warfarin is recommended for these patients.Some guidelines have now started recommending incorporating the results of genetic testing for clinical use while on warfarin therapy[42].

    Identification of thrombophilia in a child has implications in terms of the need for lifelong oral anticoagulation,increased risk of other venous thromboembolic events,lifestyle modifications like avoiding oral contraceptive pills,risk of complications like leukemia in myeloproliferative disorders,and implications for other family members.In addition,there is a need to educate asymptomatic family members regarding the risk factors and lifestyle modifications.

    CLINICAL FEATURES

    Clinical manifestations can be diverse,ranging from acute liver failure to completely asymptomatic patients,making BCS a possible differential diagnosis in many acute and chronic liver diseases.Most patients with BCS have a chronic presentation,whereas only a small number of patients present with a fulminant type of BCS[12-14].The clinical and radiological features of children with BCS in various pediatric studies are summarized in Table 2.The usual age at presentation in children is 10 (range 1.5-17) years but BCS has been reported in children as young as 4.5 mo[11,12,32].The commonest symptom is rapidly reaccumulating ascites (83%-90%) with dilated tortuous abdominal and back veins (60%-70%)[11-14,31].Up to 15%-20% of patients can be completely asymptomatic,hence a high index of suspicion should be kept,especially when there is no clear detectable etiology for chronic liver disease and/or a prothrombotic condition exists[43].In such scenarios,proper imaging by an experienced radiologist is warranted[44].The presentation of BCS depends on the extent and rapidity of hepatic venous outflow obstruction and the development of decompressing venous collaterals.With this concept,BCS can be classified as fulminant,acute,subacute,or chronic[45,46].However,a pathological examination of the liver illustrates a dissociation between the rapidity of the clinical presentation and the acuteness of the histological damage.Up to 50% of patients clinically classified as acute have histological features of chronicity (e.g.,fibrosis or cirrhosis)[46].The prognostic value of this clinical classification in predicting mortality has not been prospectively evaluated[47].Over time,several prognostic indices have been designed to predict mortality and response to therapeutic interventions[15,18,46,47].These scoring systems incorporate clinical and laboratory features to stratify patients,although their use for the management of an individual patient is debatable[48].

    Table 2 Clinical presentation,site of block,radiological intervention,and outcomes of major studies in children with Budd-Chiari syndrome

    DIFFERENCE BETWEEN ADULTS AND CHILDREN WITH BCS

    BCS can occur at any age group but it most commonly affects young adults.In adults,secondary causes of BCS are much more frequently seen than children in whom primary causes are predominant.Regarding the underlying etiology,thrombophilic conditions are reported in more than 80% of adults with BCS.In Asian children,the etiology is largely idiopathic.Thrombophilia work-up is often under-reported and the results are variable.Acquired prothrombotic conditions like MPD,APLS,PNH,sickle cell disease,and oral contraceptive pill use are predominantly seen in adults.On the contrary,inherited thrombophilias like protein C deficiency and protein S deficiency are more commonly found in children.The clinical presentation is also different for adults and children.Shuklaet al[32] compared 43 children and 129 adult patients with BCS.They found hepatomegaly without ascites as the most common presentation in children as compared to ascites being the most common presentation in adults.The authors hypothesized that children have better angiogenesis and collateral formation,and shorter disease duration,leading to milder clinical presentation and better treatment outcome.

    DIAGNOSTIC CHALLENGES

    The diagnosis of BCS depends on the demonstration of HV and/or IVC obstruction.Invasive venography remains the gold standard;however,it is performed during the time of endovascular intervention procedure.DUS has therefore emerged as the primary imaging modality with a diagnostic accuracy of > 90%[12,13,15].DUS evaluates hepatic,portal,and IVC patency,site,and length of block and liver parenchymal changes (including caudate lobe hypertrophy and intrahepatic comma-shaped collaterals).HVs may be engorged,irregular,or filled with thrombus.The “health” and residual stump of the HV are the most critical to plan an endovascular intervention.Triphasic flow may be dampened or reversed.The IVC may be narrowed or displaced by caudate hypertrophy or contain an intraluminal thrombus.Intrahepatic comma-shaped collaterals and caudate lobe hypertrophy are almost universally seen in patients with BCS.The presence of dense intrahepatic collaterals suggests chronicity.Subcapsular collaterals may bleed during a percutaneous intervention and need to be carefully documented.Non-invasive venography (CT or MRI) is required when there is a diagnostic ambiguity.Hypoenhancement of the peripheral hepatic parenchyma and relatively normal enhancement of the caudate lobe result in a mottled appearance on CT.These changes are more obvious on MRI[49].However,if they are unyielding,invasive venography and liver biopsy should be considered.

    Another challenging diagnostic dilemma in the context of BCS is hepatocellular carcinoma (HCC).Long-standing congestion and fibrosis of hepatic parenchyma in patients with chronic BCS are known to give rise to hepatic nodules.The etiology of hepatic nodules detected on radio imaging in BCS patients can be benign regenerative nodules and HCC.It is important to distinguish between these two conditions as treatment differs significantly.HCC lesions are usually larger in size (> 2 cm) and hypervascular on DUS and CT/MR[50].Also,for HCC,contrast enhancement in T1-weighted MR imaging can show different enhancement patterns between HCC with and without BCS[51].Yanget al[51],in a comparative study between 10 adult HCC patients with associated primary BCS and 32 other HCC patients without BCS,found that significantly more lesions with BCS were hyperintense during the arterial phase and slightly hyperintense or isointense during the venous phase than lesions without BCS (P< 0.05 for both).Therefore,histological confirmation is required in the workup of HCC in patients with BCS.

    TREATMENT OPTIONS

    Therapeutic options for BCS include medical management with anticoagulation therapy,radiological interventions such as angioplasty and stenting,surgical shunting and transjugular intrahepatic portosystemic shunt (TIPSS),and lastly,liver transplantation (LT).

    Medical therapy

    Anticoagulation alone with oral anticoagulants is sufficient in only 10% of adult patients,especially those with mild disease,and the vast majority of them progress,requiring intervention strategies in follow-up[52-54].Pediatric experience is limited.Sharmaet al[14] reported a 33% response in a small cohort of Indian BCS children who were treated with warfarin alone.Data on the comparative efficacy of directly acting anticoagulantsvsvitamin K antagonists in BCS patients is scarce[55].A recent Austrian multicentre study on the efficacy and safety of DOAC in 22 adult BCS patients(DOAC first-line anticoagulation in 6,switched over from warfarin and LMWH in 16) showed that DOAC showed clinical response in 63% of cases while bleeding occurred in 11 (4 major bleeding,7 minor bleeding)[55].Confirmation of efficacy and safety by larger prospective studies is needed.

    Radiological endovascular intervention

    The progressive improvement in radiological endovascular intervention (REI) techniques in the past two decades has provided better procedural and clinical success for BCS treatment compared to other treatment modalities in both adults and children[14,15,56,57].

    Angioplasty vs stenting

    The rationale of angioplasty is to decompress the liver while restoring hepatic blood flow.Angioplasty can be done with or without stenting in BCS patients with short-segment stenosis (< 5 cm).Wanget al[58],in a landmark study,compared the treatment efficacy and long-term patency of angioplasty with and without stenting in 88 adult Chinese patients with BCS.They had shown that the superiority of angioplasty with stenting over angioplasty alone in the rate of re-stenosis(2%vs40% over a median follow-up period of 27 mo,P< 0.0001)[58].Balloon angioplasty without stenting of the obstructed veins is preferred in infants and younger children as appropriate sizes of stents are not available,thus making stenting technically difficult in this population.Also due to the relatively shorter duration of disease,the veins are likely to be much more pliant.Hence angioplasty alone may reduce and normalize the venous pressure significantly after the procedure.In older children,angioplasty alone has a technical success rate and clinical response rate of 90% but is fraught with a high risk of blockage[11-15].Restenosis is almost always inevitable.Nagralet al[12],Kathuriaet al[13],and Sharmaet al[14] have reported higher re-occlusion rates with angioplasty alone (75%,33%,and 57%,respectively) compared to angioplasty+stenting (0%,13%,and 33%,respectively) and TIPSS (20%,33%,and 28%,respectively).This highlights that angioplasty with stenting rather than angioplasty alone,should be the preferred modality of radiological intervention(RI) in children.The smaller size of the liver and caliber of the veins in children pose a challenge when choosing an appropriate size and length of the stent.An uncovered self-expandable metallic stent is preferred over fully covered stents because of the lower risk of post-procedural thrombosis.Longer stents (20-30 mm) are required for long-segment IVC blocks than HV blocks.Overall,the technical success and clinical response rate of stenting in children is excellent (>90%) with a much less re-stenosis rate than angioplasty[11-15].In the authors’ experience,the length of the stent may appear longer as the liver decongests after the intervention.However,with the growth of the child,the liver also grows in size and the final stent size is usually appropriate for the child.Customized stents are available.It is also important to realize that once the liver is recovering and the physiology is restored,there is an expected sudden growth spurt in children with chronic liver disease,especially during puberty.With growth,the blood flow and turbulence through the recovering liver increase.Hence anticoagulation is most important in this phase till the stent undergoes complete endothelialization.Oral contraceptives in adolescence are to be prescribed with caution.

    TIPSS

    TIPSS is a shunt created between the portal and the systemic circulation,leading to a reduction in hepatic congestion and symptom resolution.Currently,TIPSS is performed in failed angioplasty-stenting with an available HV stump and as a bridge to LT[27].TIPSS is technically more demanding than cirrhotic patients due to the blocked HVs.Nonetheless,various studies have established TIPSS as a safe and effective treatment for BCS in adults[22,48,59,60].Amarapurkaret al[22] and Shalimaret al[59] have shown good technical success rates (87.5%-100%) and clinical success rates (80%-93%).Post-procedure encephalopathy occurs less frequently (3% to 5% cases) than in other cirrhotic patients,reflecting the relatively preserved hepatic function in most patients with BCS[59,60].The main concern about TIPSS is the higher occurrence of stent dysfunction.Compared to other cirrhotic patients undergoing TIPSS,BCS patients show higher stent dysfunction (70%vs50% within 1 year),probably due to underlying prothrombotic conditions in BCS[61].The advent of polytetrafluoroethylene covered stents has dramatically reduced the incidence of stent dysfunction (30%-70% in bare stentsvs10-20% in covered stents)[61,62].The available TIPSS stents are usually expensive and are inappropriate in terms of sizes for children,thus limiting their use in the pediatric population,although reports of successful treatment of children with BCS with TIPSS are available[12,13].TIPSS in children with BCS risks placement of the bare end of the stent beyond the portal vein and into the superior mesenteric vein if the size is too long.Hence,a “stent within a stent” is a minor modification of this technique that allows customization for the size of the liver.In this technique,a fully covered graft stent (10 mm × 3-7 cm) is placed inside the bare uncovered stent (10 mm × 8-10 cm).

    Modified TIPSS/DIPS (direct intrahepatic portosystemic shunt)

    Long-segment (> 5 cm) HV block is usually not amenable to angioplasty,stenting,or TIPSS.A modified TIPSS or DIPS is a procedure where a shunt is made between IVC and the right branch of the portal vein.Though technically challenging,DIPS has been shown to effectively decompress hepatic congestion and clinical resolution in patients with BCS.In a large pediatric study from the authors’ center,children with chronic BCS undergoing DIPS had a procedural success and clinical response rate of 80% and 90%,respectively[15].

    Surgical shunts

    The principle of a surgical portosystemic shunt is to relieve the obstruction causing PHTN using a venous conduit,thereby decompressing the hepatic sinusoids.Surgical portosystemic shunts have now been almost completely abandoned because of high perioperative mortality (25%) and poor shunt patency (70%)[63-65].Surgical portosystemic shunting can also be technically difficult when there is caudate lobe hypertrophy[66].Most studies on surgical portosystemic shunts in adult patients with BCS failed to show any survival benefit[65,67].In a case series of 25 Indian children with BCS,only one out of the four patients who underwent surgical shunts survived[68].

    LT

    LT is considered a salvage therapy in the setting of fulminant presentation,progression to end-stage liver disease,or development of HCC[27,53].BCS accounts for approximately 1% of all pediatric LT cases[69].Involvement of retrohepatic IVC,the proximity of thrombus near the right atrium,and an underlying prothrombotic condition causing vascular complications make LT challenging.The challenge is even greater when considering living donor liver transplantation(LDLT) since the graft does not contain the retrohepatic IVC,as in deceased-donor liver transplantation (DDLT).Therefore,HV reconstruction is more complex,especially if the IVC is also obliterated[69].The smaller size of vessels in children complicates the situation further.Several large retrospective analyses have evaluated the benefit of DDLT in adult BCS patients with 5-year survival rates varying between 71% and 89.4%,similar to those undergoing LT for other diseases[70,71].Due to the scarcity of deceased-donor liver grafts,LDLT has been the mainstay for BCS patients undergoing LT in most Asian countries with 5-year survival rates ranging from 75% to 81%[72-75].Data on LT in pediatric BCS is only in the form of case reports and small case series and long-term prognosis has been reported to be good so far[76,77].

    STEPWISE APPROACH OR UPFRONT REI IN CHILDREN WITH BCS: THE WAY FORWARD?

    The rarity of BCS in general makes it difficult to perform randomized controlled trials in patients with BCS.Hence,most recommendations regarding treatment are based on case reports,retrospective studies,and expert opinions.Concerning the timing of the interventions,the European Association for the Study of the Liver[78] and the Asia Pacific Association for the Study of the Liver (APASL)[27] recommended a stepwise therapeutic algorithm for BCS in adults.The algorithm depends on treatment response,medical therapy with anticoagulant drugs,angioplasty,stent placement,TIPS,and LT.In contrast to the strict step-up principle,an AASLD practical guideline suggested checking for a venous obstruction amenable for angioplasty in all symptomatic patients right at the beginning and treating accordingly[79].The step-up algorithm has also been criticized because it pays little attention to hemodynamics and its possible improvement or even relief by interventional treatment.The step-up algorithm also does not restore physiology at the onset and possibly delays the definitive procedure,leading to advanced liver disease.Guidelines are silent regarding what should be the optimal treatment approach in children with BCS.Longitudinal studies on pediatric BCS have shown that children with chronic BCS tend to decompensate early with ascites and variceal bleeding[13,14].In those receiving medical therapy alone,it has been seen that 26% of adults die over 2 years[53,55].Response to medical therapy has been variable in children (33-43%)and two-thirds of these children ultimately require an intervention in the long run[14].There is also concern about the safety profile of long-term use of oral anticoagulants in children[80].Hence,we suggest that all children with BCS(whether symptomatic or not) should undergo angioplasty and stenting as a primary treatment modality.

    It is debatable whether asymptomatic or incidentally detected BCS should be subjected to REI or not,especially in children.On one hand,decompensation may rapidly set in as children do not tolerate portal hypertension for longer periods as compared to adults.On the other hand,there are no sound ethical justifications as to whether these children should be subjected to invasive procedures and maintained on lifelong anticoagulation.In a personal opinion,the authors would prefer the former in asymptomatic children given their longer life expectancy,milder liver disease,and possibly better health and compliance with the HV.Hence there is a small window of opportunity to restore normal physiology in optimal conditions.

    POST-INTERVENTION COMPLICATIONS AND NEED FOR MONITORING AFTER REI

    Immediate complications of REI include subcapsular hematoma,hemoperitoneum,congestive heart failure,transient hepatic encephalopathy,and pulmonary thromboembolism and are encountered in 1%-3% of procedures in experienced centers[12-16,27].Long-term complications of bleeding secondary to anticoagulation have also been reported[12,13,22].However,the most commonly encountered post-procedure complication is re-stenosis after REI.Singhet al[15],in a large cohort of Indian children with BCS,reported follow-up vascular patency rates of 87%,82%,and 62% at 1,5,and 10 years after intervention,respectively.In the above study,29% of the cohort with REI (27% HV/IVC stenting;60% modified TIPSS) had restenosis[15].Adult studies report 17% to 41% restenosis after REI[21,22,24].To prevent re-stenosis,heparin infusion should be started during the intervention and continued thereafter.Warfarin must be initiated within 24 h of completing the procedure.The physician should consider stopping heparin and continuation of long-term warfarin if the target INR of 2-3 is achieved.Periodic clinical examination,liver function test,and shunt patency by DUS (post-stenting:24 h,1 wk,1 mo,3 mo,and subsequently every 6 mo;post TIPS/DIPS: at 7-14 d,3 mo,6 mo,9 mo,and 12 mo) is performed.Post-intervention surveillance aims to re-intervene before critical stenosis or occlusions recur.

    Assessment of response to therapy

    Response to therapy implies restoration of blood flow across previously blocked HV/IVC and consequent improvement in organomegaly and liver function test (LFT),no recurrence of ascites without need of diuretics,and resolution of signs of PHTN.Kathuriaet al[13],in a study among 20 children with BCS undergoing REI,demonstrated clinical and biochemical resolution in all;however,the median follow-up duration was 6.5 mo only.Sharmaet al[14],in another study of 20 Indian children with BCS who underwent REI,showed that HV stenting or TIPS is efficacious in improving clinical features,LFT,PHTN features,and growth parameters in 66% and 72% of cases,respectively,over a median follow-up duration of 44 (range 5-132) mo.Further long-term studies need to holistically address the natural history and timelines of resolution of organomegaly,liver stiffness,varices,liver functions,growth,pubertal maturity,and quality of life in children with BCS.

    LIVER AND SPLENIC STIFFNESS MEASUREMENT IN MONITORING

    Recently,liver stiffness measurement (LSM) and splenic stiffness measurement (SSM) have been extensively studied as potential non-invasive markers of hepatic and splenic fibrosis and congestion and hepatic venous pressure gradient in patients with chronic liver disease[81-84].LSM and SSM can be measured by various imaging techniques [transient elastography (TE),shear-wave elastography (SWE),and MR elastography].Fraquelliet al[82],in a study of 132 patients with chronic hepatitis B and C,showed that LSM and SSM measured by TE,were reliable in predicting significant fibrosis[odds ratio (OR)=5.2 and 4.6,respectively] and cirrhosis (OR=7.8 and 9.1,respectively).SSM of < 48 kPa by TE was useful in ruling out esophageal varices.In another study by the same authors in 186 chronic liver disease patients,LSM and SSM measured by SWE were equally effective and reliable in predicting significant liver fibrosis as compared to TE,with SWE having the advantage of applicability in patients with obesity or ascites[83].The latest Baveno VII guidelines recommended that all cases of clinically advanced chronic liver disease should undergo LSM testing[85].

    However,these tests are yet not standardized in children.Pediatric literature regarding LSM and SSM by elastography techniques is emerging.Chongsrisawaet al[86] reported significantly higher LSM in biliary atresia patients with esophageal varices than those without (37.72 ± 21.55vs10.97 ± 8.71 kPa,P< 0.001).Yoonet al[87] showed that an LSM value of > 18.4 kPa predicted clinically significant PH (CSPH) in children with CLD with a high sensitivity (87.5%) and specificity (84.0%).LSM has been used to monitor and assess treatment response in adult patients with BCS[88].In a study to assess short-and long-term outcomes in 32 Chinese adults with BCS undergoing REI,Wanget al[88] measured LSM using SWE at 2 d,3 mo,and 6 mo post-procedure.Mean LSM value before the procedure was 35.17 ± 10.60 kPa,which decreased to 15.36 ± 4.34 kPa and 15.68 ± 5.58 kPa at 3 mo and 6 mo post-procedure,respectively (P< 0.001).Published literature on the role of LSM in monitoring children with BCS is scarce[89].Dohareet al[89] evaluated the role of LSM in 32 children undergoing REI and showed that LSM values decreased significantly after REI.A maximal decrease is seen 24 h after REI (43.7 kPa at baselinevs22.5 kPa 24 h post-procedure,P=0.001)[75].Among the nine children developing re-stenosis after REI,re-stenosis was typically associated with an increase in LSM compared with the patient's prior measurement (median absolute increase 11.0 kPa;interquartile range [IQR] 6.1-24.4).

    SSM reflects congestion as well as structural changes in the spleen as a direct consequence of the increased PHT[90,91].SSM is considered a direct and more suitable surrogate marker of PHTN and performs better for the prediction of CSPH[91,92] and esophageal varices[93,94].Suttonet al[94] evaluated SSM in 67 children with chronic liver disease and showed that SSM is a reliable predictor of CSPH at a value > 38.0 kPa [area under receiver operating curve (AUROC)=0.92,sensitivity=89%,specificity=82%,P< 0.01].Sintuseket al[95] studied 51 BA children and showed a higher SSM of 46.85(IQR 25.95-54.55) kPa in patients with varices as compared to the no-varices group [median SSM-16.54 (IQR 11.75-21.75)kPa;P< 0.001].SSM has been performed in adults with BCS (n=7) who underwent TIPSS[96].In this case series,SSM in combination with LSM may reflect the severity of the disease at presentation and the need for invasive treatment.SSM values also showed a significant decline after TIPSS over a median follow-up period of 1 year.Further studies are required to elucidate the role of LSM and SSM in monitoring BCS patients after REI.

    PROGNOSTIC INDICES AND THEIR IMPLICATIONS

    To date,many prognostic scores have been developed in patients with BCS to quantify the disease severity and prognosis(Table 3).The authors evaluated the prognostic accuracy of these indices in BCS children and found that pre-intervention PELD score with a cut-off of 4 (AUROC=0.809,86% sensitivity,and 75% specificity) significantly determined poor outcomes following REI.Zeitoun score independently predicted poor outcome [OR=15.4,95% confidence interval (CI):1.17-203.56,P=0.04] with a cut-off of 4.3 (AUROC=0.923,83% sensitivity,and 77% specificity) in the unintervened chronic BCS[15].Hence BCS children with a Zeitoun index > 4.3 should undergo REI without any delay.

    LONG-TERM COMPLICATIONS OF BCS

    Hepatopulmonary syndrome

    Hepatopulmonary syndrome (HPS) occurs in a substantial portion (28%) of adult patients with BCS and balloon angioplasty can reverse HPS in patients with BCS[97].The mechanism is unknown but may be related to portal decompression.This may also explain the favorable outcomes of TIPSS creation for HPS in patients with cirrhosis and idiopathic PHTN[98].Sharmaet al[14] in a previous pediatric study reported the detection of HPS among five children in long-term follow-up,one in an un-intervened child and four after RI with patent stent (3 TIPSS,1 HV angioplasty).It is not clear as to which patients will have resolution or progress to HPS as contradicting outcomes have been noted.The possible reason for developing HPS even after reduction of portal hypertension post-RI could be increased exposure of pulmonary vasculature to vasodilator mediators like increased levels of nitric oxide,endothelin-1,tumor necrosis factor-α,and endotoxemia[98].

    HCC is an uncommon but dreaded long-term complication of BCS[99,100].In a recent systematic review of adults,the prevalence of HCC in BCS is geographically varied[99].It is documented as 2.0%-46.2% in 12 Asian studies,40.0%-51.6%in two African studies,11.3% in one European study,and 11.1% in one American study[99].Irrespective of hepatitis as the underlying risk factor of HCC,the pooled prevalence of HCC was 17.6% in BCS patients (95%CI: 10.1%-26.7%),26.5%in IVC obstruction (95%CI: 14.4%-40.7%),and 4.2% in HV obstruction (95%CI: 1.6%-7.8%).When patients with HCC and concomitant hepatitis were excluded,the pooled prevalence of HCC was 15.4% (95%CI: 6.8%-26.7%).Only 3 out of the 16 included studies evaluated the risk factors for the development of HCC in BCS patients.However,there was significant heterogeneity among these studies and the results were contradicting[99].Further long-term prospective studies are necessary to evaluate risk factors for HCC in BCS patients.Data regarding the prevalence of HCC in children with BCS is limited.So far,only three cases of HCC in children with BCS have been reported[14,32,101].All of them had HCC in the 2nddecade of life,liver nodules > 3 cm,and elevated alpha-fetoprotein.One patient was on anticoagulation only[101]while the other two had blocked stents[14,32].In the authors’ own unpublished experience from the authors' center,an 18-year-old boy developed HCC 6 years after blockage of DIPS.Routine surveillance for HCC is thus warranted in BCS patients,even after undergoing REI.

    FUTURE DIRECTIONS

    Future studies need to elucidate the underlying thrombophilic conditions and their role in the etiopathogenesis of BCS.The use of next-generation sequencing in addition to the conventional thrombophilia work-up is warranted for better understanding and higher diagnostic yield.Further studies are needed to determine the precise role of MRA in differentiating benign liver nodules with HCC in BCS patients.Liver and splenic stiffness measurement by elastography techniques (transient elastography,shear-wave elastography,and MR elastography) may serve as a useful non-invasive marker for assessing treatment response.Despite its rarity,pediatric BCS provides a unique opportunity to study the natural history,long-term complications,and treatment outcome.

    CONCLUSION

    BCS is a rare but potentially treatable cause of portal hypertension with an excellent prognosis after definitive treatment.Due to recent advances in interventional radiology,radiological endovascular intervention is currently the preferred primary treatment modality.Better patient and procedure selection,choice of appropriate size and type of stent,and mandatory follow-up assessment are of utmost importance for better long-term outcomes.In future,prospective and larger studies should be undertaken to study the epidemiology and establish standardized diagnostic and therapeutic management protocols for pediatric BCS.

    FOOTNOTES

    Author contributions:Samanta A contributed to literature review,analysis,data collection and interpretation,and drafting of the initial manuscript;Sen Sarma M contributed to the conception and design of the manuscript,interpretation of the data,and critical revision of the initial manuscript;Yadav R contributed to interpretation of the data and the critical revision of the initial manuscript;all the authors approved the final version of the manuscript.

    Conflict-of-interest statement:All the authors declare no conflict of interest for this article.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers.It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license,which permits others to distribute,remix,adapt,build upon this work non-commercially,and license their derivative works on different terms,provided the original work is properly cited and the use is non-commercial.See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:India

    ORCID number:Arghya Samanta 0000-0002-1768-0263;Moinak Sen Sarma 0000-0003-2015-4069;Rajanikant Yadav 0000-0002-6955-850X.

    S-Editor:Liu JH

    L-Editor:Wang TQ

    P-Editor:Cai YX

    熟女人妻精品中文字幕| 精品一区二区三区av网在线观看| 在线播放无遮挡| 免费av不卡在线播放| 亚洲精品在线观看二区| 亚洲欧美成人综合另类久久久 | 国产精品福利在线免费观看| 哪里可以看免费的av片| 国产精品久久视频播放| 精品久久久久久成人av| 国产午夜精品论理片| 寂寞人妻少妇视频99o| 国内揄拍国产精品人妻在线| 亚洲av一区综合| 国产精品美女特级片免费视频播放器| 啦啦啦韩国在线观看视频| 一级黄色大片毛片| 国产精品无大码| 国产精品人妻久久久影院| 国模一区二区三区四区视频| 国产乱人偷精品视频| 黄色一级大片看看| 搡女人真爽免费视频火全软件 | 99热精品在线国产| 欧美一区二区精品小视频在线| 亚州av有码| 一边摸一边抽搐一进一小说| 免费黄网站久久成人精品| 国产探花极品一区二区| 最新中文字幕久久久久| 性插视频无遮挡在线免费观看| 亚洲av不卡在线观看| 两性午夜刺激爽爽歪歪视频在线观看| 久久精品久久久久久噜噜老黄 | 免费高清视频大片| 午夜爱爱视频在线播放| 午夜日韩欧美国产| 波多野结衣高清无吗| 色哟哟·www| 在现免费观看毛片| 国产精品电影一区二区三区| 男人舔奶头视频| 亚洲精品粉嫩美女一区| 少妇熟女欧美另类| 国产午夜精品论理片| 日日啪夜夜撸| 成年女人永久免费观看视频| 非洲黑人性xxxx精品又粗又长| 日韩大尺度精品在线看网址| 亚洲经典国产精华液单| 中文字幕av在线有码专区| 国产伦精品一区二区三区四那| 国产精品一区二区性色av| 欧美日本亚洲视频在线播放| 国产一区二区在线av高清观看| 久久6这里有精品| 我要搜黄色片| 老司机影院成人| 性欧美人与动物交配| 国产 一区 欧美 日韩| 国产亚洲精品av在线| 欧美最新免费一区二区三区| 深夜a级毛片| 亚洲内射少妇av| 亚洲欧美日韩卡通动漫| 一级黄片播放器| 欧美高清性xxxxhd video| 小蜜桃在线观看免费完整版高清| 亚洲一区二区三区色噜噜| 两个人的视频大全免费| 日韩强制内射视频| av女优亚洲男人天堂| 国产91av在线免费观看| 在线播放无遮挡| 欧美区成人在线视频| 免费看a级黄色片| 在线免费观看的www视频| 亚洲av一区综合| 蜜桃亚洲精品一区二区三区| 日日摸夜夜添夜夜添小说| h日本视频在线播放| 又粗又爽又猛毛片免费看| av免费在线看不卡| 嫩草影院入口| 夜夜夜夜夜久久久久| 成人鲁丝片一二三区免费| 国产单亲对白刺激| 97超碰精品成人国产| 免费看a级黄色片| 久久人人爽人人爽人人片va| 中国美女看黄片| 99热6这里只有精品| 男女那种视频在线观看| 99久久九九国产精品国产免费| 久久久久久九九精品二区国产| 亚洲成人精品中文字幕电影| 丰满人妻一区二区三区视频av| 免费看美女性在线毛片视频| 狂野欧美白嫩少妇大欣赏| 亚洲精品乱码久久久v下载方式| 春色校园在线视频观看| 又爽又黄无遮挡网站| 欧美潮喷喷水| 在线天堂最新版资源| 蜜臀久久99精品久久宅男| 国产私拍福利视频在线观看| 91久久精品国产一区二区成人| 久久精品夜色国产| 亚洲av不卡在线观看| 免费观看精品视频网站| 亚洲国产高清在线一区二区三| 少妇人妻一区二区三区视频| 听说在线观看完整版免费高清| 熟女人妻精品中文字幕| 亚洲欧美日韩高清在线视频| av福利片在线观看| 亚洲激情五月婷婷啪啪| 亚洲av.av天堂| 狠狠狠狠99中文字幕| 非洲黑人性xxxx精品又粗又长| 精品久久久久久久久久久久久| 亚洲人与动物交配视频| 天堂av国产一区二区熟女人妻| 高清午夜精品一区二区三区 | 99久久中文字幕三级久久日本| 国产精品女同一区二区软件| 国产精品嫩草影院av在线观看| av专区在线播放| 中文亚洲av片在线观看爽| 欧美日韩精品成人综合77777| 亚洲最大成人av| 国产精品嫩草影院av在线观看| 精品人妻一区二区三区麻豆 | 精品一区二区三区人妻视频| 精品乱码久久久久久99久播| 岛国在线免费视频观看| 最近2019中文字幕mv第一页| 日日摸夜夜添夜夜添小说| 永久网站在线| 长腿黑丝高跟| 国产真实乱freesex| 国产在线精品亚洲第一网站| 久久精品91蜜桃| 亚洲国产精品sss在线观看| 免费看a级黄色片| 国产精品电影一区二区三区| 免费看美女性在线毛片视频| 亚洲av.av天堂| 成年女人永久免费观看视频| 午夜激情欧美在线| 日韩在线高清观看一区二区三区| 自拍偷自拍亚洲精品老妇| av国产免费在线观看| www.色视频.com| 激情 狠狠 欧美| 日日摸夜夜添夜夜爱| 观看美女的网站| 亚洲精品粉嫩美女一区| 欧美+亚洲+日韩+国产| 人妻丰满熟妇av一区二区三区| 麻豆一二三区av精品| 亚洲av五月六月丁香网| 寂寞人妻少妇视频99o| 亚洲电影在线观看av| 久久久久久久久久成人| 午夜免费男女啪啪视频观看 | 国产毛片a区久久久久| 中文字幕av在线有码专区| 日日摸夜夜添夜夜添av毛片| 亚洲无线观看免费| 欧美绝顶高潮抽搐喷水| 国内精品一区二区在线观看| h日本视频在线播放| 亚洲中文字幕一区二区三区有码在线看| 日韩一本色道免费dvd| 亚洲精品成人久久久久久| 国产精品一区二区三区四区久久| 亚洲av一区综合| 日本黄色片子视频| 91在线观看av| 日产精品乱码卡一卡2卡三| 免费高清视频大片| 亚洲人与动物交配视频| 午夜精品一区二区三区免费看| 99国产极品粉嫩在线观看| 99在线人妻在线中文字幕| 深爱激情五月婷婷| 麻豆精品久久久久久蜜桃| 丝袜喷水一区| 国产伦一二天堂av在线观看| 搡老岳熟女国产| 综合色丁香网| 嫩草影院入口| 成人一区二区视频在线观看| 国产精品福利在线免费观看| 欧美性猛交╳xxx乱大交人| 一卡2卡三卡四卡精品乱码亚洲| 少妇熟女aⅴ在线视频| 国产 一区精品| 免费看美女性在线毛片视频| 国产大屁股一区二区在线视频| 变态另类成人亚洲欧美熟女| 精品午夜福利在线看| 国产成人影院久久av| 又爽又黄a免费视频| 国产高清不卡午夜福利| 久久婷婷人人爽人人干人人爱| 免费搜索国产男女视频| 日本在线视频免费播放| 亚洲国产日韩欧美精品在线观看| 久久人人精品亚洲av| 成年女人永久免费观看视频| 最近最新中文字幕大全电影3| 亚洲精品一卡2卡三卡4卡5卡| 亚洲欧美清纯卡通| 亚洲人成网站在线观看播放| 国产私拍福利视频在线观看| 久久草成人影院| 久久精品91蜜桃| 午夜亚洲福利在线播放| 人妻丰满熟妇av一区二区三区| 欧美丝袜亚洲另类| 国产精品一二三区在线看| 97超碰精品成人国产| 国产精品av视频在线免费观看| 国产欧美日韩一区二区精品| 少妇熟女aⅴ在线视频| 国产精品一区二区三区四区久久| 91精品国产九色| 国产精品1区2区在线观看.| 变态另类丝袜制服| 午夜久久久久精精品| 日韩人妻高清精品专区| 性色avwww在线观看| 禁无遮挡网站| 久久久久免费精品人妻一区二区| 久久精品国产自在天天线| 亚洲精品久久国产高清桃花| 欧美+日韩+精品| 九九久久精品国产亚洲av麻豆| 97热精品久久久久久| 精品久久久久久久久久久久久| 国产高清视频在线播放一区| 舔av片在线| 精品日产1卡2卡| 亚洲中文字幕日韩| 欧美一区二区亚洲| 久久久久精品国产欧美久久久| 日本黄大片高清| 国产精品女同一区二区软件| 中文字幕人妻熟人妻熟丝袜美| 12—13女人毛片做爰片一| 综合色丁香网| 日韩欧美国产在线观看| 国产精品无大码| 一个人观看的视频www高清免费观看| 老女人水多毛片| av天堂在线播放| 欧美激情在线99| 欧美一级a爱片免费观看看| 男人舔奶头视频| 日本爱情动作片www.在线观看 | 婷婷六月久久综合丁香| 可以在线观看的亚洲视频| 欧美高清成人免费视频www| 婷婷色综合大香蕉| 久久九九热精品免费| 亚洲成av人片在线播放无| 欧美bdsm另类| 国产美女午夜福利| 看免费成人av毛片| 深爱激情五月婷婷| 午夜久久久久精精品| 91午夜精品亚洲一区二区三区| 国产黄色小视频在线观看| 中文字幕人妻熟人妻熟丝袜美| 老熟妇仑乱视频hdxx| 日本免费a在线| 极品教师在线视频| 亚洲人成网站在线播放欧美日韩| 美女xxoo啪啪120秒动态图| 高清毛片免费看| 国内少妇人妻偷人精品xxx网站| 免费大片18禁| 久久久精品大字幕| 久久人人精品亚洲av| 俺也久久电影网| 国产在线男女| www.色视频.com| 久久人人爽人人片av| 欧美不卡视频在线免费观看| 九色成人免费人妻av| 国产精品久久久久久久久免| 日韩国内少妇激情av| 国产精品国产三级国产av玫瑰| 国产亚洲欧美98| 天天一区二区日本电影三级| 日韩制服骚丝袜av| 国产精品一二三区在线看| 国语自产精品视频在线第100页| 国产男人的电影天堂91| 国产精品伦人一区二区| 国内精品美女久久久久久| 岛国在线免费视频观看| 又爽又黄a免费视频| 国产真实伦视频高清在线观看| 99久久精品国产国产毛片| 91在线观看av| 久久久久久久久久黄片| 国产91av在线免费观看| 精品人妻偷拍中文字幕| 久久午夜亚洲精品久久| 成人永久免费在线观看视频| 日韩欧美一区二区三区在线观看| 在线免费观看不下载黄p国产| 欧美不卡视频在线免费观看| 俄罗斯特黄特色一大片| 成人综合一区亚洲| 欧美bdsm另类| 欧美成人精品欧美一级黄| 国产免费一级a男人的天堂| 午夜亚洲福利在线播放| 日日摸夜夜添夜夜添小说| 精华霜和精华液先用哪个| 亚洲最大成人手机在线| 99久久九九国产精品国产免费| 免费高清视频大片| 天堂网av新在线| 少妇人妻一区二区三区视频| 麻豆国产av国片精品| 日韩,欧美,国产一区二区三区 | 亚洲人成网站在线观看播放| 国产一区二区亚洲精品在线观看| 亚洲人成网站在线播| 91久久精品电影网| 一个人观看的视频www高清免费观看| 免费人成在线观看视频色| 日韩中字成人| 秋霞在线观看毛片| 成人永久免费在线观看视频| 激情 狠狠 欧美| 国产综合懂色| 午夜福利18| 最后的刺客免费高清国语| 欧美+日韩+精品| 一区福利在线观看| 校园春色视频在线观看| 男人舔奶头视频| 成人无遮挡网站| 中文资源天堂在线| 亚洲精品粉嫩美女一区| 九九爱精品视频在线观看| 男人舔女人下体高潮全视频| 熟女人妻精品中文字幕| 永久网站在线| 免费人成视频x8x8入口观看| 亚洲性久久影院| 国产精品久久久久久精品电影| 国产中年淑女户外野战色| 不卡视频在线观看欧美| 国产黄a三级三级三级人| 国产精品久久电影中文字幕| 国产三级中文精品| 久久午夜亚洲精品久久| 亚洲精品一卡2卡三卡4卡5卡| 久久久久久大精品| 在线国产一区二区在线| 丰满人妻一区二区三区视频av| aaaaa片日本免费| 亚洲国产高清在线一区二区三| 综合色丁香网| 人人妻人人看人人澡| 国产精品免费一区二区三区在线| 校园春色视频在线观看| 少妇人妻一区二区三区视频| 在线观看午夜福利视频| 不卡视频在线观看欧美| 乱人视频在线观看| 啦啦啦韩国在线观看视频| 精华霜和精华液先用哪个| 亚洲婷婷狠狠爱综合网| 99久久精品一区二区三区| 少妇人妻一区二区三区视频| 干丝袜人妻中文字幕| 欧美三级亚洲精品| 毛片一级片免费看久久久久| 伊人久久精品亚洲午夜| a级毛片a级免费在线| 亚洲第一电影网av| 国产一区二区三区av在线 | 欧美中文日本在线观看视频| 国产女主播在线喷水免费视频网站 | 免费电影在线观看免费观看| 老司机福利观看| 人人妻,人人澡人人爽秒播| 日韩亚洲欧美综合| 成人特级黄色片久久久久久久| 亚洲va在线va天堂va国产| 国内精品一区二区在线观看| 午夜亚洲福利在线播放| 赤兔流量卡办理| 天堂动漫精品| 尤物成人国产欧美一区二区三区| 最好的美女福利视频网| 可以在线观看的亚洲视频| 国产av麻豆久久久久久久| 久久热精品热| 麻豆国产97在线/欧美| 欧美3d第一页| 免费av不卡在线播放| 色综合站精品国产| 日本黄色片子视频| 少妇的逼水好多| 美女大奶头视频| 午夜福利视频1000在线观看| 国产精品不卡视频一区二区| 久久这里只有精品中国| 午夜爱爱视频在线播放| 国产精品一区二区三区四区免费观看 | 国产一区二区在线观看日韩| 中国国产av一级| 免费看日本二区| 欧美日本视频| 99久久久亚洲精品蜜臀av| av天堂久久9| 三上悠亚av全集在线观看 | 亚洲欧美一区二区三区国产| 午夜福利网站1000一区二区三区| 亚洲综合精品二区| 黄色一级大片看看| 欧美日韩视频高清一区二区三区二| 日韩欧美一区视频在线观看 | 中文字幕亚洲精品专区| a级毛片在线看网站| 日本黄色片子视频| 一级,二级,三级黄色视频| 色婷婷久久久亚洲欧美| 亚洲成人av在线免费| 伊人亚洲综合成人网| 99久久精品热视频| 国产淫片久久久久久久久| 精品视频人人做人人爽| 免费观看在线日韩| 久久人人爽人人爽人人片va| 国产 精品1| 伦精品一区二区三区| 日本-黄色视频高清免费观看| 一级毛片 在线播放| 国内精品宾馆在线| 久久久久久久久久人人人人人人| 精品卡一卡二卡四卡免费| 成人免费观看视频高清| 日日摸夜夜添夜夜爱| 国产精品99久久久久久久久| 欧美日韩视频高清一区二区三区二| 午夜影院在线不卡| 亚洲精品色激情综合| 日本欧美视频一区| 国产国拍精品亚洲av在线观看| 黄色欧美视频在线观看| 亚洲av男天堂| 美女中出高潮动态图| 亚洲国产欧美在线一区| 成人美女网站在线观看视频| 免费不卡的大黄色大毛片视频在线观看| 国产亚洲av片在线观看秒播厂| 日本wwww免费看| 妹子高潮喷水视频| 亚洲精品亚洲一区二区| 国产精品99久久99久久久不卡 | 国产成人一区二区在线| 丰满迷人的少妇在线观看| 欧美97在线视频| 亚洲内射少妇av| 亚洲三级黄色毛片| 少妇人妻久久综合中文| 涩涩av久久男人的天堂| 日韩大片免费观看网站| 欧美一级a爱片免费观看看| 日韩三级伦理在线观看| 午夜福利,免费看| 天堂8中文在线网| 国产探花极品一区二区| 视频中文字幕在线观看| 久久久久国产网址| av在线播放精品| 欧美高清成人免费视频www| 精品久久国产蜜桃| 亚洲人成网站在线观看播放| av一本久久久久| 91精品一卡2卡3卡4卡| 久久影院123| 观看免费一级毛片| 亚洲一级一片aⅴ在线观看| 一级爰片在线观看| 777米奇影视久久| 午夜影院在线不卡| 午夜久久久在线观看| 久久久欧美国产精品| 免费久久久久久久精品成人欧美视频 | 成人二区视频| 69精品国产乱码久久久| 亚洲人成网站在线播| 国产成人精品婷婷| 午夜免费观看性视频| 多毛熟女@视频| kizo精华| 黄色怎么调成土黄色| 九九在线视频观看精品| 日韩免费高清中文字幕av| 国产av码专区亚洲av| 老司机亚洲免费影院| 天天操日日干夜夜撸| 在线 av 中文字幕| 中文天堂在线官网| a 毛片基地| 这个男人来自地球电影免费观看 | 丝袜脚勾引网站| 午夜福利网站1000一区二区三区| 色婷婷久久久亚洲欧美| 日韩人妻高清精品专区| 久久99热6这里只有精品| 国产 一区精品| 欧美日韩亚洲高清精品| 成人国产麻豆网| 高清在线视频一区二区三区| 各种免费的搞黄视频| 91精品一卡2卡3卡4卡| 天堂8中文在线网| 久久久久国产网址| 亚洲国产最新在线播放| 黄色日韩在线| 久久精品国产亚洲网站| 日韩中字成人| 乱人伦中国视频| 色吧在线观看| 少妇精品久久久久久久| 亚州av有码| 久久精品国产亚洲av涩爱| 亚洲,一卡二卡三卡| 内射极品少妇av片p| 午夜福利视频精品| 精品国产一区二区三区久久久樱花| 久久久久国产精品人妻一区二区| 少妇人妻一区二区三区视频| 熟妇人妻不卡中文字幕| 五月玫瑰六月丁香| 九九爱精品视频在线观看| 在线观看三级黄色| 久久毛片免费看一区二区三区| 综合色丁香网| 久久久久国产网址| 黄色视频在线播放观看不卡| 亚洲精品日韩在线中文字幕| 在线免费观看不下载黄p国产| 一区二区三区精品91| 国产精品伦人一区二区| 少妇人妻久久综合中文| 特大巨黑吊av在线直播| 少妇丰满av| 一级爰片在线观看| 欧美国产精品一级二级三级 | 欧美 亚洲 国产 日韩一| 自拍偷自拍亚洲精品老妇| 久久久久久久亚洲中文字幕| 校园人妻丝袜中文字幕| 久久人妻熟女aⅴ| 如何舔出高潮| 日韩av免费高清视频| 国产黄片美女视频| 水蜜桃什么品种好| 亚洲综合色惰| 在线精品无人区一区二区三| 在现免费观看毛片| 少妇丰满av| 赤兔流量卡办理| 国语对白做爰xxxⅹ性视频网站| 91aial.com中文字幕在线观看| 亚洲av成人精品一区久久| 天美传媒精品一区二区| 国产成人精品无人区| 狠狠精品人妻久久久久久综合| 国产亚洲午夜精品一区二区久久| 久久国产精品大桥未久av | 色吧在线观看| 国产精品99久久久久久久久| 国产精品嫩草影院av在线观看| 免费播放大片免费观看视频在线观看| 精品久久久噜噜| 成人18禁高潮啪啪吃奶动态图 | 狠狠精品人妻久久久久久综合| 午夜av观看不卡| 欧美日韩亚洲高清精品| 99久久中文字幕三级久久日本| 久久婷婷青草| 人人澡人人妻人| 性高湖久久久久久久久免费观看| 国产精品久久久久久av不卡| 日本与韩国留学比较| 熟妇人妻不卡中文字幕| xxx大片免费视频| 男女无遮挡免费网站观看| 国产成人a∨麻豆精品| 两个人的视频大全免费| 久久99热6这里只有精品| 99久久精品热视频| 亚洲第一av免费看| 精品一区在线观看国产| 五月开心婷婷网| 女性被躁到高潮视频| 欧美精品人与动牲交sv欧美| 亚洲精品成人av观看孕妇| 3wmmmm亚洲av在线观看| 欧美精品高潮呻吟av久久| 国产男人的电影天堂91|